Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Wound healing improvement by a multicomponent wound dressing of keratinocyte-imprinted polydimethylsiloxane substrate in a rabbit model.

Alipour S., Shams D., Samani S., Pourkhodadad S., Yasami-Khiabani S., Banaeianzadeh S.

Animal Study on Chronic Wound, published in Sci Rep (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Sci Rep (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
41309868
PMCID
PMC12660737
DOI
10.1038/s41598-025-26525-9
Citations
1

Abstract (original English)

Wound healing is a major clinical challenge and regenerative medicine and tissue engineering suggest new ways to overcome such problems. The cell imprinting method can provide cues that regulate cell function or modulate stem cell differentiation into different lineages. In this study, the rabbit keratinocyte-imprinted polydimethylsiloxane (PDMS) substrate (KiPDMS) was made and associated with adipose-derived stem cells (ADSCs), keratinocytes, and collagen scaffold, provided various treatments. After evaluating ADSCs' differentiation into keratinocytes by qPCR and immunocytochemistry techniques, different treatments were implanted in a rabbit ear, histopathological analysis was performed on measuring the epidermal thickness and neovascularization. The histopathological analysis revealed that treated groups increased epidermal thickness (~ 139% up to ~ 998%) and neovascularization (vessel count /mm 2 , ~ 111% to ~ 301%) compared to the control group. Collagen scaffolds stimulated re-epithelialization, and implanting ADSCs with or without other factors enhanced its effect. Adding KiPDMS significantly improved re-epithelialization and neovascularization, especially in combination with differentiated keratinocytes. The complete treatment, consisting of all cellular and non-cellular stimulating factors, associated with a significant improvements in re-epithelialization and neovascul

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsRabbitsKeratinocytesDimethylpolysiloxanesWound HealingCell DifferentiationBandagesTissue ScaffoldsDisease Models, AnimalCollagen

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research